Caxton Associates (UK)’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,180
Closed -$305K 926
2025
Q4
$305K Buy
+1,180
New +$269K 0.01% 614
2025
Q3
Sell
-1,013
Closed -$212K 863
2025
Q2
$212K Buy
+1,013
New +$195K 0.01% 622

Other funds holding MSGS

Caxton Associates (UK)'s MSGS Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 1,180 shares — an estimated $305K sold.

Caxton Associates (UK) first reported a position in MSGS in Q2 2025 and held it in 2 quarters. The position peaked at $305K in Q4 2025. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 1,180 Madison Square Garden shares in Q1 2026, an estimated $305K.
  • Caxton Associates (UK) first reported a position in Madison Square Garden in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Madison Square Garden position peaked at $305K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.